These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 9655280
21. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up. Khalkhali I, Cutrone J, Mena I, Diggles L, Venegas R, Vargas H, Jackson B, Klein S. J Nucl Med; 1995 Oct; 36(10):1784-9. PubMed ID: 7562043 [Abstract] [Full Text] [Related]
22. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography. Fenlon HM, Phelan NC, O'Sullivan P, Tierney S, Gorey T, Ennis JT. Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988 [Abstract] [Full Text] [Related]
23. New method for breast cancer detection using TC-99m sestamibi scintimammography. Yuen-Green M, Wasnich R, Caindec-Ranchez S, Davis J. Hawaii Med J; 1996 Feb; 55(2):26-8. PubMed ID: 8820628 [Abstract] [Full Text] [Related]
24. Contribution of 99mTc-MIBI scintimammography to the diagnosis of non-palpable breast lesions in relation to mammographic probability of malignancy. Carril JM, Gómez-Barquín R, Quirce R, Tabuenca O, Uriarte I, Montero A. Anticancer Res; 1997 Feb; 17(3B):1677-81. PubMed ID: 9179217 [Abstract] [Full Text] [Related]
25. Technetium-99m-sestamibi scintimammography for the detection of breast carcinoma: comparison between planar and SPECT imaging. Tiling R, Tatsch K, Sommer H, Meyer G, Pechmann M, Gebauer K, Münzing W, Linke R, Khalkhali I, Hahn K. J Nucl Med; 1998 May; 39(5):849-56. PubMed ID: 9591588 [Abstract] [Full Text] [Related]
26. Technetium-99m sestamibi in the diagnosis of breast cancer. The Mayagüez Medical Center experience. Farías-Jimenez J, Rivera A, Carlo VM. Bol Asoc Med P R; 2001 May; 93(1-12):9-11. PubMed ID: 12755069 [Abstract] [Full Text] [Related]
33. Scintimammography with 99mTc-MIBI and magnetic resonance imaging in the evaluation of breast cancer. Bagni B, Franceschetto A, Casolo A, De Santis M, Bagni I, Pansini F, Di Leo C. Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1383-8. PubMed ID: 12910383 [Abstract] [Full Text] [Related]
34. Tc-99m MDP scintimammography in palpable and nonpalpable breast lesions: comparison with mammographic probability of malignancy. Atasever T, Ozdemir A, Turkölmez S, Altinok M, Isik S. Anticancer Res; 1999 Oct; 19(4C):3601-6. PubMed ID: 10629658 [Abstract] [Full Text] [Related]
35. Initial evaluation of breast cancer using Tc-99m sestamibi scintimammography. Tiling R, Kessler M, Untch M, Sommer H, Linke R, Hahn K. Eur J Radiol; 2005 Feb; 53(2):206-12. PubMed ID: 15664284 [Abstract] [Full Text] [Related]
36. Limited value of scintimammography and contrast-enhanced MRI in the evaluation of microcalcification detected by mammography. Tiling R, Khalkhali I, Sommer H, Linke R, Moser R, Willemsen F, Pfluger T, Tatsch K, Hahn K. Nucl Med Commun; 1998 Jan; 19(1):55-62. PubMed ID: 9515547 [Abstract] [Full Text] [Related]
40. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results]. Prats E, Carril J, Herranz R, Meroño E, Banzo J, Gtemegmmt YE. Rev Esp Med Nucl; 1998 Jan; 17(5):338-50. PubMed ID: 9812008 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]